Yasunori Aizawa

Company: Logomix Biotechnology

Job title: Chief Scientific Officer

Seminars:

Geno-Writing™: The iPSC Genome Engineering Engine for Tomorrow’s Cell Therapy 3:00 pm

Pioneering best-in-class genome engineering technologies for human iPSC engineering Leveraging the Geno-Writing™ platform, we are developing advanced genome designs to enhance hypoimmunity The Geno-Writing™ platform has recently been applied to achieve more precise differentiation of iPSCs for T1D cell therapyRead more

day: Day One Track A Afternoon